Omeza Receives FDA Clearance for Omeza Collagen Matrix

Omeza's products include its collagen matrix, far right.

Omeza, the Sarasota-based pores and skin science firm, lately introduced that the U.S. Meals and Drug Administration (FDA) has cleared its Omeza Collagen Matrix by the FDA’s 510(ok) premarket notification course of. Omeza Collagen Matrix is Omeza’s first prescription product, and the primary drug/system mixture matrix of its sort for power wound care.

Omeza Collagen Matrix is a wound care matrix comprised of hydrolyzed fish collagen infused with cod liver oil, which acts as an anhydrous pores and skin protectant, and different plant-derived oils and waxes. When utilized to a wound floor, the matrix is of course integrated into the wound over time. It’s designed for intimate contact with each common and irregular wound beds to offer a conducive atmosphere for the affected person’s pure wound therapeutic course of. The product contains a no-prep software equipped in unit-dose vials. It’s meant for the administration of wounds together with partial- and full-thickness wounds, stress ulcers, venous ulcers, diabetic ulcers, power vascular ulcers, tunneled/undermined wounds, surgical wounds (donor websites/grafts, post-Mohs surgical procedure, post-laser surgical procedure, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, superficial partial thickness burns, pores and skin tears) and draining wounds.



Leave a comment

Your email address will not be published. Required fields are marked *